Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Journal of Translational Medicine
|
July 31, 2024
Targeting tumor-infiltrating CCR8<sup>+</sup> regulatory T cells induces antitumor immunity through functional restoration of CD4<sup>+</sup> T<sub>convs</sub> and CD8<sup>+</sup> T cells in colorectal cancer
Qian Chen, Meiying Shen, Min Yan, et al.
Frontiers in Medicine
|
November 7, 2022
Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infection
Song Mu, Shuyi Song, Yanan Hao, et al.
Zhonghua Yi Xue Za Zhi
|
January 3, 2004
[Identification of immunological effector cells after autologous cytokine-induced killer cells treatment and its clinical implication in hepatocellular carcinoma patients]
Ming Shi, Bing Zhang, Zi-rong Tang, et al.
Frontiers in Immunology
|
December 24, 2021
A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant Strains
Fengxia Gao, Jingjing Huang, Tingting Li, et al.
Chemosphere
|
June 17, 2011
Bioaccumulation, maternal transfer and elimination of polybrominated diphenyl ethers in wild frogs
Peng-Yan Liu, Guo-Dong Du, Ya-Xian Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 11, 2013
Phase Ib study of panobinostat and bortezomib in relapsed or relapsed and refractory multiple myeloma
Jesús F San-Miguel, Paul G Richardson, Andreas Günther, et al.
Molecular Medicine Reports
|
January 17, 2014
Cytokine IL-6 is required in Citrobacter rodentium infection-induced intestinal Th17 responses and promotes IL-22 expression in inflammatory bowel disease
Lei Li, Qing-Guo Shi, Fang Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2009
The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of CH4987655 in healthy volunteers: target suppression using a biomarker
Lucy Lee, Huifeng Niu, Ruediger Rueger, et al.
Cancer Medicine
|
July 6, 2024
Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors
Agostina Stradella, Melissa Johnson, Sanjay Goel, et al.
Acta Pharmacologica Sinica
|
January 16, 2026
UBC9-mediated p53 SUMOylation drives tubular senescence and exacerbates acute kidney injury in mice
Qi-Mei Wu, Jing Liu, Ying-Song Mu, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Journal of Translational Medicine
|
July 31, 2024
Targeting tumor-infiltrating CCR8<sup>+</sup> regulatory T cells induces antitumor immunity through functional restoration of CD4<sup>+</sup> T<sub>convs</sub> and CD8<sup>+</sup> T cells in colorectal cancer
Qian Chen, Meiying Shen, Min Yan, et al.
Frontiers in Medicine
|
November 7, 2022
Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infection
Song Mu, Shuyi Song, Yanan Hao, et al.
Zhonghua Yi Xue Za Zhi
|
January 3, 2004
[Identification of immunological effector cells after autologous cytokine-induced killer cells treatment and its clinical implication in hepatocellular carcinoma patients]
Ming Shi, Bing Zhang, Zi-rong Tang, et al.
Frontiers in Immunology
|
December 24, 2021
A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant Strains
Fengxia Gao, Jingjing Huang, Tingting Li, et al.
Chemosphere
|
June 17, 2011
Bioaccumulation, maternal transfer and elimination of polybrominated diphenyl ethers in wild frogs
Peng-Yan Liu, Guo-Dong Du, Ya-Xian Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 11, 2013
Phase Ib study of panobinostat and bortezomib in relapsed or relapsed and refractory multiple myeloma
Jesús F San-Miguel, Paul G Richardson, Andreas Günther, et al.
Molecular Medicine Reports
|
January 17, 2014
Cytokine IL-6 is required in Citrobacter rodentium infection-induced intestinal Th17 responses and promotes IL-22 expression in inflammatory bowel disease
Lei Li, Qing-Guo Shi, Fang Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2009
The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of CH4987655 in healthy volunteers: target suppression using a biomarker
Lucy Lee, Huifeng Niu, Ruediger Rueger, et al.
Cancer Medicine
|
July 6, 2024
Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors
Agostina Stradella, Melissa Johnson, Sanjay Goel, et al.
Acta Pharmacologica Sinica
|
January 16, 2026
UBC9-mediated p53 SUMOylation drives tubular senescence and exacerbates acute kidney injury in mice
Qi-Mei Wu, Jing Liu, Ying-Song Mu, et al.
Page
of 7